October/November #191 : No Detectable HIV in Two Men After Stem Cell Transplants - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


¡El SIDA Sí Da!

Cut to Fit

From the Editor

Rie y Llora


Letters-October/November 2013


Unidos Podemos

POZ Planet

Thank You, Sean Sasser

On the March

Get Lucky

Friend Request

Then There Were None

Why Should Gay and Bi Latino Men Get Tested?

Say What? Zombie Edition


Obamacare is Here

Care and Treatment

Reduced Dose of Sustiva Succeeds

New Ways to Beat Gonorrhea

Lower Bone Density Linked to Number of ARV Regimens

No Detectable HIV in Two Men After Stem Cell Transplants

WHO Revises Treatment Guidelines

Research Notes

Prevention: HIV Test May Help Improve Vaccines

Treatment: Normal Mortality Risk if Undetectable?

Cure: Cord Blood Transplant Aftermath

Concerns: Early Treatment in Developing World

POZ Heroes

A Test of Kindness

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

October / November 2013

No Detectable HIV in Two Men After Stem Cell Transplants

by Benjamin Ryan

Super sensitive tests have not been able to detect any virus in two HIV-positive men after each received reduced-intensity chemotherapy followed by stem cell transplants to treat lymphoma. A third man in the study died of recurrent lymphoma, although researchers did observe a reduction in his HIV reservoir.

When researchers reported their findings in July, one of the men had gone 15 weeks without a viral rebound since stopping his antiretrovirals, and the other had gone seven weeks.

Qualifying his study results as “exciting and encouraging,” Timothy Henrich, MD, of Harvard Medical School, says, “It may take a year, or up to a year and a half before we’re able to say that the chances of HIV returning are very, very low.” At that point, Henrich says, he would define the men as “in remission off therapy.”

Unlike Timothy Brown, a.k.a the Berlin Patient, who was functionally cured of HIV and leukemia following two bone marrow transplants from a donor with a rare genetic resistance to HIV, these men did not receive such genetically resistant cells. The researchers theorize the treatment succeeded at least in part because of what’s known as graft-versus-host disease in which newly transplanted cells attack the old, HIV-infected ones, which have been weakened by chemotherapy. The disease can be fatal if left unchecked, so both men received rounds of immunosuppressive therapies and steroids.

Henrich stresses that it would be unethical to provide such a treatment, which has a 15 to 20 percent mortality rate, to anyone who does not already need it as a cancer therapy.

Search: stem cell transplant, lymphoma, HIV reservoir, Timothy Henrich, MD, Harvard Medical School, Timothy Brown, Berlin Patient

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.